Published by Michele Maatouk on 19th December 2017
(ShareCast News) - Hikma Pharmaceuticals has reached a licensing agreement with South Korea-based Celltrion for Truxima ((rituximab), the first biosimilar monoclonal antibody in oncology to be granted European marketing authorisation.
URL: http://www.digitallook.com/dl/news/story/26844180/...